RxDoctor Payments Data

Britt Short, APRN

Family · Liberal, KSNPI 1659559540

Payments from drug & device makers

$983in general payments, 2019–2025

Across 50 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$249
  • Dexcom, Inc.$147
  • Smith+Nephew$136
  • AbbVie$68
  • Organogenesis Inc.$62
  • Sumitomo Pharma America, Inc.$56
  • plus $265 from 8 others

What the payments were for

  • Food & beverage$983100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$983 in reported general payments places this provider in the 70th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$42,116
Medicare patients
137
Services billed
649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol87$58,763
OzempicSemaglutide44$39,765
JardianceEmpagliflozin31$23,388
Janumet XrSitagliptin Phos/Metformin Hcl19$15,322
JanumetSitagliptin Phos/Metformin Hcl26$14,671
Xigduo XrDapaglifloz Propaned/Metformin19$12,105
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$10,359
Spiriva RespimatTiotropium Bromide12$5,926
Combivent RespimatIpratropium/Albuterol Sulfate11$5,058
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$2,317
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$1,845
SynthroidLevothyroxine Sodium15$1,598
CholestyramineCholestyramine (With Sugar)24$1,292
Levothyroxine Sodium124$1,162
Pantoprazole Sodium90$1,136

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$249$69,122104 claims
Novo NordiskOzempic$46$39,76544 claims
MerckJanumet Xr, Janumet$30$29,99445 claims
AbbVieSynthroid$68$1,59815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,579 family providers in Kansas.

Other family in Liberal

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →